Oh and you do realise that two of AGY's own business cases for the 10 ktpa expansion CAPEX were estimated at US$215.2m, don't you? This was clearly highlighted in the 2018 PEA. The US$140.9m figure was a "best case" scenario only. Decide for yourself how likely AGY is to achieve a "best case" CAPEX budget, when the 2 ktpa plant was meant to cost ~USD$20m but ended up costing close to double that figure, and that's still excluding the ponds and the ongoing mechanical improvements that are still burning funds.
Now, take AGY's own US$215.2m business case figure and add 30% inflation (your chosen figure, not mine).
US$215.2m x 1.3 = USD$279.76m. Low and behold, that's right within my estimate CAPEX range as well.
- Forums
- ASX - By Stock
- AGY
- General Discussion AGY
General Discussion AGY, page-18275
-
- There are more pages in this discussion • 5,211 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AGY (ASX) to my watchlist
|
|||||
Last
3.7¢ |
Change
-0.004(9.76%) |
Mkt cap ! $53.86M |
Open | High | Low | Value | Volume |
3.9¢ | 4.0¢ | 3.7¢ | $70.04K | 1.807M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 919478 | 3.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.9¢ | 225251 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 919478 | 0.037 |
11 | 1472352 | 0.036 |
26 | 3362797 | 0.035 |
12 | 2096154 | 0.034 |
12 | 2413451 | 0.033 |
Price($) | Vol. | No. |
---|---|---|
0.039 | 225251 | 1 |
0.040 | 413812 | 4 |
0.041 | 451993 | 4 |
0.042 | 242305 | 5 |
0.043 | 298646 | 4 |
Last trade - 16.10pm 13/08/2024 (20 minute delay) ? |
Featured News
AGY (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online